History of the discovery and clinical introduction of chlorpromazine.
about
Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesiaChlorpromazine for psychosis induced aggression or agitationA bibliometric study of scientific research conducted on second-generation antipsychotic drugs in SingaporeAntimicrobial photodynamic therapy for inactivation of biofilms formed by oral key pathogensMonoaminergic and Histaminergic Strategies and Treatments in Brain DiseasesNeuropsychopharmacology of auditory hallucinations: insights from pharmacological functional MRI and perspectives for future research.Classics in Chemical Neuroscience: Aripiprazole.The role of rodent models in the discovery of new treatments for schizophrenia: updating our strategy.Mitochondria, oligodendrocytes and inflammation in bipolar disorder: evidence from transcriptome studies points to intriguing parallels with multiple sclerosisTargeting the dopamine receptor in schizophrenia: investigational drugs in Phase III trials.Who pioneered the use of antipsychotics in North America?Drug development in pediatric psychiatry: current status, future trends.PhenoPredict: A disease phenome-wide drug repositioning approach towards schizophrenia drug discoveryQuo Vadis Clozapine? A Bibliometric Study of 45 Years of Research in International Context.Interference of the complex between NCS-1 and Ric8a with phenothiazines regulates synaptic function and is an approach for fragile X syndrome.Behavioral and emotional adverse events of drugs frequently used in the treatment of bipolar disorders: clinical and theoretical implications.Trends in scientific literature on atypical antipsychotics in South Korea: a bibliometric studyDisease signatures for schizophrenia and bipolar disorder using patient-derived induced pluripotent stem cells.Barbiturates Bind in the GLIC Ion Channel Pore and Cause Inhibition by Stabilizing a Closed State.Hypothermia associated with antipsychotic drug use: a clinical case series and review of current literature.Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs.New approaches to the management of schizophrenia: focus on aberrant hippocampal drive of dopamine pathways.Weighing the evidence for harm from long-term treatment with antipsychotic medications: A systematic review.Using Intermediate Cognitive Endpoints to Facilitate Translational Research in Psychosis.A molecular pathway analysis stresses the role of inflammation and oxidative stress towards cognition in schizophrenia.Control of the Cutaneous Circulation by the Central Nervous System.Extensions to In Silico Bioactivity Predictions Using Pathway Annotations and Differential Pharmacology Analysis: Application to Xenopus laevis Phenotypic Readouts.Antipsychotic inductors of brain hypothermia and torpor-like states: perspectives of application.Another view of the history of antipsychotic drug discovery and development.Differential interference of chlorpromazine with the membrane interactions of oncogenic K-Ras and its effects on cell growth.Hypothermia due to Antipsychotic Medication: A Systematic ReviewThe story of antipsychotics: Past and present.Delusional parasitosis: Worms of the mind.Problems and solutions to filling the drying drug pipeline for psychiatric disorders: a report from the inaugural 2012 CINP Think Tank.Comparative extrapyramidal effects of Rauwolfia vomitoria, chlorpromazine and reserpine in mice.Neuroprotection by Chlorpromazine and Promethazine in Severe Transient and Permanent Ischemic Stroke.The pharmacogenetics of medications used in general anesthesia.Clozapine, chlorpromazine and risperidone dose-dependently reduce emotional hyperthermia, a biological marker of salience.Ready biodegradability of trifluoromethylated phenothiazine drugs, structural elucidation of their aquatic transformation products, and identification of environmental risks studied by LC-MS( n ) and QSARA bibliometric review of drug repurposing.
P2860
Q24186530-89B36FEF-B2FF-436D-B2A2-A1AF87B2E2ACQ24235748-01AE2EFF-85B1-4137-9993-D6C79B7E7C54Q26994688-27B9326A-1B90-4102-87CE-7F9C99C6D12DQ27016118-68EDAEC2-21C4-41B9-9CC0-B030D98674A7Q28066691-18F7474C-E350-41EC-B1F4-F21139B9591DQ30582343-AAE06D42-CD01-4521-940F-F65CB825FBB9Q33866125-31F4EBBF-F131-4741-8828-AEF804341209Q34140126-47C65883-8879-42F6-AFE3-269BD21907F3Q35053349-15EF0ECB-9E42-466E-A22F-3F8463A63E1AQ35071909-D01E3D51-1363-46F0-AC36-823AB44399ADQ35566094-C84AAD22-27E0-48F9-AB48-8B5BCD0A6301Q35811894-AAAFF5E6-52E6-4BFF-AF10-1811F974D807Q36109996-0D02210F-A7BE-41B0-8810-8BA1C9F0392CQ36184331-97EC5EC9-7898-4241-8F41-018D58A137AAQ36259253-782B6A5D-69B4-4723-8BA8-730949CDEBF5Q36582018-A0E6B302-B258-4E64-9441-8507FBC472ADQ36662907-B8AAA327-6BDF-476F-BA81-ADE2DF4AE811Q36902087-357CBCC9-CE28-4ADA-BC6C-E2A7C85BACB6Q37623366-CD5A6F90-34A0-4179-8985-92A11B4BBE5BQ37940318-AAC0E778-649E-446E-8E60-A050953E09A1Q38056146-B8FB2325-C607-497D-8D34-7C3B9ED7DBF2Q38233857-11047BD9-5708-48A8-81B2-BB9A61F2DADFQ38664662-C953FE1E-A60C-4794-B693-7F3D438D7B94Q38670526-5FBD4612-D3B9-44ED-96E0-F2456C851B7BQ38801096-931CAC9F-D86F-4527-9C05-D968C9AEC0B9Q38848104-2608B133-F075-4A80-AF5F-3773ECBE0AC1Q38915525-6865B89B-EC3C-4824-A1E8-E9DA8EB780E9Q39033778-75EE4ACA-8F0B-46CB-BD12-A982C17E0739Q39569838-1749A134-E8FB-4701-9014-B2CBF6B6BC72Q39951891-6ECCE009-24BE-45BB-9882-A402DCC9EE9FQ41314374-348A366E-1EC0-457D-B48D-7576CC8A2053Q42019820-0B7E6BF7-E401-40B0-88DB-064838269A58Q42148247-D933F40C-3DEE-4D9B-BE88-D5840C49ADC9Q43450643-AED0B6A7-053E-4160-9F55-F3166765EE5CQ46297168-1CA7891E-4AEF-47CF-9913-6D8B3F65C26CQ46453538-AEF6B069-17A6-421A-ACFD-376E5697860CQ47213395-9F169E6E-4391-458D-963E-A30E56DA2F52Q47413227-337EBFE5-2D7F-46E7-8431-F46175D24668Q47650039-E5938414-3AE5-454A-9430-9AC245B636BCQ50059772-331B96B7-3131-4061-AF3E-7A03868B99D1
P2860
History of the discovery and clinical introduction of chlorpromazine.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
History of the discovery and clinical introduction of chlorpromazine.
@ast
History of the discovery and clinical introduction of chlorpromazine.
@en
History of the discovery and clinical introduction of chlorpromazine.
@nl
type
label
History of the discovery and clinical introduction of chlorpromazine.
@ast
History of the discovery and clinical introduction of chlorpromazine.
@en
History of the discovery and clinical introduction of chlorpromazine.
@nl
prefLabel
History of the discovery and clinical introduction of chlorpromazine.
@ast
History of the discovery and clinical introduction of chlorpromazine.
@en
History of the discovery and clinical introduction of chlorpromazine.
@nl
P2093
P1476
History of the discovery and clinical introduction of chlorpromazine.
@en
P2093
Cecilio Alamo
Eduardo Cuenca
Francisco López-Muñoz
Gabriel Rubio
Patrick Clervoy
Winston W Shen
P304
P356
10.1080/10401230591002002
P577
2005-07-01T00:00:00Z